Zim Laboratories

90.61
+1.35
(1.51%)
Market Cap
441.50 Cr
EPS
3.54
PE Ratio
28.38
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
131.40
52 Week Low
79.49
PB Ratio
1.79
Debt to Equity
0.40
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,744.90
#1 4,18,659.96
35.62
#1 49,887.20
12.06
#1 9,648
13.77
55.14
5,891.50
1,56,400.81
72.42
8,184.00
0.89
1,600
#1 64.53
57.37
1,511.10
1,22,038.69
24.53
26,520.70
14.17
4,155
47.38
57.37
3,254.60
1,10,150.45
59.16
10,785.70
11.59
1,656
13.54
56.98
2,588.40
1,06,791.83
52.20
10,615.60
19.57
1,942
-16.38
65.89
1,177.40
98,248.77
#1 18.08
28,905.40
12.36
5,578
1.69
56.93
2,009.20
91,728.21
30.83
20,141.50
#1 19.94
1,936
38.82
50.80
845.35
85,061.99
18.45
19,831.50
13.82
3,831
29.92
42.63
1,201.20
69,765.89
19.31
29,559.20
17.55
3,169
-10.04
60.21
30,915.00
65,692.22
48.86
6,097.20
10.80
1,201
16.01
57.97
Growth Rate
Revenue Growth
-7.98 %
Net Income Growth
-29.51 %
Cash Flow Change
-57.35 %
ROE
-40.82 %
ROCE
-39.99 %
EBITDA Margin (Avg.)
-13.45 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
64
64
75
79
71
72
99
95
69
68
74
72
71
88
76
75
65
78
87
107
95
101
103
106
69
87
97
119
83
94
98
Expenses
57
55
64
62
62
61
85
84
64
63
65
62
60
81
67
65
59
67
76
90
82
87
88
90
63
77
85
102
74
83
85
EBITDA
7
9
11
17
9
11
13
11
4
5
9
9
11
8
8
10
7
11
11
16
13
14
16
16
6
11
13
17
9
11
13
Operating Profit %
11 %
13 %
15 %
13 %
12 %
14 %
13 %
11 %
5 %
7 %
11 %
10 %
15 %
9 %
10 %
12 %
8 %
13 %
12 %
14 %
12 %
12 %
13 %
15 %
7 %
11 %
12 %
13 %
10 %
10 %
12 %
Depreciation
2
2
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
5
4
4
4
4
5
5
5
Interest
2
3
2
3
3
3
3
3
3
3
3
3
3
3
2
3
3
3
2
1
1
1
2
1
2
1
2
2
3
3
3
Profit Before Tax
3
4
7
11
4
5
8
5
-2
-2
2
3
4
1
2
3
0
4
6
11
8
8
10
10
0
5
7
11
1
3
6
Tax
1
1
1
3
0
1
2
3
-3
-1
0
0
1
0
1
1
0
1
2
4
2
3
3
3
0
1
2
3
0
1
2
Net Profit
2
3
6
8
4
3
6
2
0
-1
2
2
3
1
1
2
0
3
4
7
5
5
7
7
0
4
5
8
1
2
4
EPS in ₹
2.66
1.79
7.81
4.84
2.35
2.08
3.65
1.43
0.05
-0.37
0.94
1.41
2.02
0.73
0.80
0.95
0.12
2.00
2.51
4.33
3.17
3.35
1.35
1.48
0.05
0.85
0.98
1.66
0.18
0.49
0.82

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
265
256
259
298
329
325
325
342
342
447
Fixed Assets
87
92
89
94
106
116
107
106
109
161
Current Assets
168
154
154
173
194
182
192
212
191
228
Capital Work in Progress
6
3
4
8
13
10
11
12
27
42
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
172
161
166
196
209
200
208
224
206
244
Total Liabilities
265
256
259
298
329
325
325
342
342
447
Current Liabilities
133
122
113
141
155
143
142
146
111
159
Non Current Liabilities
38
35
28
20
22
28
22
20
30
49
Total Equity
94
99
118
137
151
154
161
176
200
239
Reserve & Surplus
86
91
110
129
135
138
145
160
152
190
Share Capital
8
8
8
8
16
16
16
16
49
49

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-7
-0
-0
1
-1
1
-0
2
3
3
Investing Activities
-9
-12
-7
-26
-21
-19
-6
-14
-36
-73
Operating Activities
6
22
32
37
35
22
32
49
38
16
Financing Activities
-4
-10
-25
-10
-15
-2
-26
-33
1
60

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.21 %
0.01 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.11 %
0.10 %
0.24 %
0.24 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.73 %
51.92 %
51.96 %
50.67 %
50.77 %
51.15 %
50.96 %
51.57 %
51.57 %
49.90 %
50.74 %
50.92 %
49.01 %
49.21 %
45.48 %
44.39 %
47.78 %
Others
36.01 %
14.81 %
14.77 %
16.06 %
15.97 %
15.59 %
15.78 %
15.17 %
15.16 %
16.84 %
15.99 %
15.82 %
17.72 %
17.42 %
21.15 %
21.90 %
18.71 %
No of Share Holders
4,600
4,887
4,610
3,646
3,561
3,569
3,643
5,595
5,879
8,982
15,305
17,342
17,100
17,483
17,716
17,450
17,448

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 28, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMar 28, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 28, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 13, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Integrated Filing (Financial)Feb 10, 2025
Q3 & 9M FY25 - Earnings PresentationFeb 10, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2024 Is Enclosed Herewith.Feb 10, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 10.02.2025Feb 10, 2025
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended 31St December 2024.Feb 03, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2025
Change Of Name Of The Registrar And Share Transfer Agent ("RTA") Of The CompanyJan 02, 2025
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 10, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 06, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 06, 2024
Reply To The Clarification Sought On Increase In Trading Volume Of The Shares Of The CompanyDec 05, 2024
Clarification sought from Zim Laboratories LtdDec 05, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 03, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 03, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateDec 02, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 02, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2024
Announcement under Regulation 30 (LODR)-Credit RatingNov 25, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 19, 2024
Announcement under Regulation 30 (LODR)-Updates on AcquisitionNov 15, 2024
Announcement under Regulation 30 (LODR)-Updates on AcquisitionNov 15, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 15, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 11, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 11, 2024
Q2 & H1 FY25 - Earnings PresentationNov 09, 2024
Financial Results For The Quarter And Half Year Ended 30Th September, 2024Nov 09, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementNov 09, 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 09.11.2024Nov 09, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 05, 2024
Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligations& Disclosure Requirements) Regulations, 2015Nov 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 29, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 17, 2024
Announcement under Regulation 30 (LODR)-Credit RatingOct 09, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024

Technical Indicators

RSI(14)
Neutral
57.00
ATR(14)
Less Volatile
4.48
STOCH(9,6)
Neutral
76.64
STOCH RSI(14)
Overbought
88.92
MACD(12,26)
Bullish
1.11
ADX(14)
Weak Trend
21.80
UO(9)
Bearish
48.24
ROC(12)
Uptrend And Accelerating
12.52
WillR(14)
Overbought
-16.32